|
|
|
|
| LEADER |
01888nam a2200457Ia 4500 |
| 001 |
34456642 |
| 003 |
OCoLC |
| 005 |
19960416133313.0 |
| 008 |
960325s1995 mdua b f000 0 eng d |
| 040 |
|
|
|a GPO
|b eng
|c GPO
|
| 043 |
|
|
|a n-us---
|
| 049 |
|
|
|a COMN
|
| 074 |
|
|
|a 0507-H-17
|
| 086 |
0 |
|
|a HE 20.9002:Z 3
|
| 088 |
|
|
|a HRSA-BD-SP-96-2
|
| 245 |
0 |
0 |
|a Program advisory :
|b use of zidovudine (ZDV) to reduce perinatal HIV transmission in HRSA-funded programs.
|
| 246 |
3 |
0 |
|a Use of zidovudine (ZDV) to reduce perinatal HIV transmission in HRSA-funded programs.
|
| 264 |
|
1 |
|a [Rockville, Md.?] :
|b U.S. Dept. of Health & Human Services, Public Health Service, Health Resources & Services Administration,
|c [1995]
|
| 300 |
|
|
|a ii, 30 pages :
|b illustrations ;
|c 28 cm.
|
| 336 |
|
|
|a text
|b txt
|2 rdacontent.
|
| 337 |
|
|
|a unmediated
|b n
|2 rdamedia.
|
| 338 |
|
|
|a volume
|b nc
|2 rdacarrier.
|
| 500 |
|
|
|a Cover title.
|
| 500 |
|
|
|a Shipping list no.: 96-0162-P.
|
| 500 |
|
|
|a "December 1995."
|
| 500 |
|
|
|a "HRSA-BD-SP-96-2"--P. [2] of cover.
|
| 504 |
|
|
|a Includes bibliographical references (page 20).
|
| 650 |
|
0 |
|a AZT (Drug)
|
| 650 |
|
0 |
|a HIV infections
|z United States
|x Prevention.
|
| 650 |
|
0 |
|a AIDS (Disease) in infants
|z United States
|x Prevention.
|
| 650 |
|
0 |
|a Neonatal infections
|z United States
|x Prevention.
|
| 710 |
1 |
|
|a United States.
|b Health Resources and Services Administration.
|
| 907 |
|
|
|a .b12695804
|b cug
|c -
|d 010628
|e 230519
|
| 998 |
|
|
|a cug
|b 010601
|c m
|d a
|e -
|f eng
|g mdu
|h 0
|i 0
|
| 902 |
|
|
|a 060630
|
| 948 |
|
|
|a MARCIVE Comp, in 2022.12
|
| 948 |
|
|
|a MARCIVE August, 2017
|
| 948 |
|
|
|a MARCIVE extract Aug 5, 2017
|
| 995 |
|
|
|a Loaded with m2btab.ltiac in 2022.12
|
| 995 |
|
|
|a Loaded with m2btab.ltiac in 2017.08
|
| 989 |
|
|
|a HE 20.9002:Z 3
|d cusgb
|b 1080004464351
|e - -
|f - -
|g -
|h 0
|i 0
|j 18
|k 010628
|l $0.00
|m
|n - -
|o -
|p 0
|q 0
|t 0
|x 0
|1 .i1402374x
|